학술논문
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial
Document Type
Article
Author
Rhein, J.; Pastick, K.A.; Williams, D.A.; Abassi, M.; Meya, D.B.; Boulware, D.R.; Huppler Hullsiek, K.; Bangdiwala, A.S.; Nicol, M.R.; Tugume, L.; Mpoza, E.; Kiggundu, R.; Ssebambulidde, K.; Akampurira, A.; Musubire, A.K.; Nuwagira, E.; Evans, E.E.; Muzoora, C.; Ndyetukira, J.F.; Ahimbisibwe, C.; Kugonza, F.; Namuju, C.; Sadiq, A.; Namudde, A.; Mwesigye, J.; Tadeo, K.K.; Kirumira, P.; Okirwoth, M.; Luggya, T.; Kaboggoza, J.; Laker, E.; Atwine, L.; Muganzi, D.; Walukaga, S.; Jawed, B.; Merry, M.; Stadelman, A.; Stephens, N.; Flynn, A.G.; Fujita, A.W.; Kwizera, R.; Mukaremera, L.; Lofgren, S.M.; Cresswell, F.V.; Morawski, B.M.; Bahr, N.C.; Nielsen, K.
Source
In: The Lancet Infectious Diseases . (The Lancet Infectious Diseases, August 2019, 19(8):843-851)
Subject
Language
English
ISSN
14744457
14733099
14733099